Register Now
Why register?
Login
 The leading web portal for pharmacy resources, news, education and careers May 29, 2017
Pharmacy Choice - News - Pharmaceutical Industry Trends and Policy - May 29, 2017

Pharmacy News

 Pharmaceutical Industry Trends and Policy
Current Articles | 7 - 30 Days Old | 30 - 90 Days Old | Over 90 Days
Articles(s): 1 - 25 of 250     Next >>     Go To Page:

5/28/17 - 5 Top NASDAQ Biotech Stocks: Nutraceutical Gained 48.93 Percent
Last week the Congressional Budget Office revealed the GOP replacement to Obamacare would end up nixing insurance coverage to 26 million american citizens by 2026 in an attempt to reduce $119 billion over the next decade. FDA head Scott Gottlieb announced it would remove the federal hiring freeze to his agency. Nutraceutical CytRx MannKind MEI Phar
5/28/17 - Findings from Bentley University Broaden Understanding of Clinical Trials and Studies (Timelines of translational science: From technology initiation...
By a News Reporter-Staff News Editor at Medical Letter on the CDC& FDA Current study results on Clinical Research- Clinical Trials and Studies have been published. We examined timelines of translational science for 138 drugs and biologicals approved by the FDA from 2010-2014 using an analytical model of technology maturation. " Our news journalis
5/28/17 - Purchase Along With The Delivery Of Oncological Drugs, Generic Drugs And Nutrition For The Hospital Pharmacy Of The Swietokrzyskie Center Of Oncology In Kielce. [TendersInfo (India)]
Contract notice: Purchase along with the delivery of oncological drugs, generic drugs and nutrition for the hospital pharmacy of the Swietokrzyskie center of oncology in kielce. Detailed description of the object of the order together with specification of assortment, quantity and quality requirements falling within the scope of the subject of...
5/28/17 - Researchers Submit Patent Application, "Method of Treating Hyperlipidemia and Atherosclerosis with Mir-30c", for Approval (USPTO 20170121713)
By a News Reporter-Staff News Editor at Heart Disease Weekly From Washington, D.C., NewsRx journalists report that a patent application by the inventors Hussain, Mahmood; Soh, James, filed on January 12, 2017, was made available online on May 11, 2017. The patent's assignee is The Research Foundation for The State University of New York. News edi
5/28/17 - Safety events common for pharmaceuticals and biologics after FDA approval
By a News Reporter-Staff News Editor at Medical Letter on the CDC& FDA Among more than 200 new pharmaceuticals and biologics approved by the U.S. Food and Drug Administration from 2001 through 2010, nearly a third were affected by a postmarket safety event such as issuance of a boxed warning or safety communication, according to a study published
5/28/17 - Vet doctors decry indiscriminate use of antibiotics
NIGERIA Veterinary Medical Association, NVMA has decried the indiscriminate use of antibiotics in Nigeria hospitals and farms, insisting that the antibacterial drug resistance was spreading at an alarming rate in the country. Godwin Abonyi, who spoke during this year s World Veterinary Day celebration held in Asaba, warned that that the use of..
5/28/17 - Veterinary Medicines And Vaccines For The Prevention And Treatment Of Cattle And Pigs [TendersInfo (India)]
Tenders are invited for Veterinary medicines and vaccines for the prevention and treatment of cattle and pigs Major organization: PUBLIC AGRICULTURAL UNITARY ENTERPRISE "BORDER-AGRO" Address: Republic of Belarus, Grodno region., AG Edge, 231773, ul.
5/27/17 - "Combination Pharmaceutical Composition and Methods of Treating Diseases Or Conditions Associated with Neurodegenerative Diseases" in Patent...
"Combination Pharmaceutical Composition and Methods of Treating Diseases Or Conditions Associated with Neurodegenerative Diseases" in Patent Application Approval Process. By a News Reporter-Staff News Editor at Obesity, Fitness& Wellness Week A patent application by the inventor Epshtein, Oleg Iliich, filed on January 3, 2017, was made available
5/27/17 - "Method for Preparing Azetidinone Compound and Intermediate of Azetidinone Compound" in Patent Application Approval Process (USPTO 20170121281)
By a News Reporter-Staff News Editor at Obesity, Fitness& Wellness Week A patent application by the inventors BAI, Hua; ZHAO, Xuyang; ZHANG, Yuncai; LI, Xufei; ZHANG, Yong; XU, Dezhou; ZHANG, Li; XU, Xiaojie; ZHU, Qifeng; WANG, Xiaoming; YANG, Zhiqing; ZHONG, Zehua; ZHANG, Jian, filed on June 5, 2015, was made available online on May 11, 2017, ac
5/27/17 - Abide Therapeutics Announces Dosing of First Subject in fMRI Imaging Study to Investigate Brain Activity Patterns Associated with ABX-1431
By a News Reporter-Staff News Editor at Obesity, Fitness& Wellness Week Abide Therapeutics, a developer of innovative pharmaceuticals, announced initiation of dosing in a Phase 1 study using functional magnetic resonance imaging to evaluate patterns of neural activity in the brain associated with oral administration of ABX-1431, a first-in-class.
5/27/17 - Accelerated FDA approval and pricey drugs make a rotten combo, doctors argue [Tehran Times (Iran)]
Should drugs that win FDA approval on an accelerated pathoften without strong evidence of efficacycommand the same high prices as products that undergo the full menu of agency scrutiny? The ideaswhich include lower prices until drugs prove themselves out in confirmatory trialscome amid an unprecedented debate over the price tags on drugs in the U.S
5/27/17 - Analysis of the Congressional Budget Office's Estimate of the House-Passed Affordable Care Act Repeal Legislation
The AHCA would benefit wealthy households and insurance and drug companies at the expense of low and moderate-income individuals who would be harmed by radical cuts to Medicaid and much reduced premium tax credits to purchase health care in the Affordable Care Act's marketplaces. CBO/JCT project that losses will occur due to the proposal's repeal o
5/27/17 - Attorney General Becerra Announces $33M Nationwide Settlement After Maker of Tylenol, Motrin, Benadryl Produced Adulterated Medicine
California Attorney General Xavier Becerra issued the following news release:. California Attorney General Xavier Becerra announced a $33 million settlement with drug manufacturer Johnson& Johnson after it violated federal regulations between 2009 and 2011 that ensure the quality of certain medicines, including many consumed by children.
5/27/17 - BioCryst gets a big boost from its latest HAE data, but it still faces a dangerous high wire act and giant rivals [Tehran Times (Iran)]
A little more than a year ago, shares of Research Triangle Park, NC- based BioCryst$ BCRX were crushed by a failed Phase II trial for their lead drug for hereditary angioedema, or HAE. Setbacks like that are not new for BioCryst. But the biotech turned to another HAE drug coming up the pipeline.
5/27/17 - Brewery, prescription drug and General Assembly videos pass into law without Hogan's signature [The Frederick News-Post, Md.]
Larry Hogan announced Friday that new laws to address prescription drug price gouging, General Assembly video recording and brewery taproom expansions will take effect without his signature. Others including a multi-state congressional redistricting plan and a paid sick leave measure that passed with veto-proof majorities in the House and Senat
5/27/17 - Calcimedica gets fast track status for CRAC channel inhibitor `CM4620` to treat acute pancreatitis [Tehran Times (Iran)]
Privately-held CalciMedica, announced that it received Fast-Track designation from the US Food and Drug Administration for its lead clinical compound, CM4620, a novel, calcium release-activated calcium channel inhibitor, for the treatment of acute pancreatitis. "We are very pleased to receive Fast-Track designation for CM4620, which may allow us t
5/27/17 - Cancer scientist tries to help others as he battles his own Stage 4 cancer [The San Diego Union-Tribune]
The lanky, low-key and bearded Point Loma Heights resident has a doctorate in medicinal chemistry and is the co-inventor of Zykadia, an FDA- approved lung cancer drug made by his employer, the massive Switzerland- based pharmaceutical company, Novartis. Four years later, that personal project, with the help of the advocacy group Fight Colorectal Ca
5/27/17 - Celldex`s Immuno-Oncology Pipeline Continues to Impress [Sudan Tribune]
On May 25, we issued an updated research report on Hampton, NJ- based Celldex Therapeutics, Inc. CLDX. So far this year, Celldex`s share price has been trading below the Zacks categorized Medical-Biomed/Genetics industry. Revenues rose 15.3% year over year to $1.5 million in the quarter, beating the Zacks Consensus Estimate of $0.57 million.
5/27/17 - Concert Pharmaceuticals, Lexington, Mass., Assigned Patent for Morphinan Compounds
Concert Pharmaceuticals, Lexington, Massachusetts, has been assigned a patent developed by two co-inventors for morphinan compounds. The co-inventors are Philip B. Graham, Carlisle, Massachusetts, and I. Robert Silverman, Arlington, Massachusetts. Written by Amal Ahmed; edited by Sudarshan Harpal.
5/27/17 - Continuing Support for Prescription Drug Monitoring Program, McCaskill Advocates for County-Level Funding
Following her successful work to ensure county and municipal level prescription drug monitoring programs would be eligible for federal funds, U.S. Senator Claire McCaskill lent her support to the St. Louis County monitoring program grant application, which includes programs from thirteen additional cities and counties across the state and covers ne
5/27/17 - Daewoong Pharmaceutical Pushes into U.S. BTX Market [Syrian Arab News Agency]
With its self-developed botulinum toxin Nabota, Daewoong Pharmaceutical Co. is waking up from its long winter sleep. According to investment banking industry sources on May 25, the stock price of Daewoong Pharmaceutical decreased to as low as 60,000 won last year due to the overall stock price adjustment in the pharmaceutical industry and conflict
5/27/17 - FDA panel backs Pfizer biosim to blockbuster anemia meds from Amgen, Johnson & Johnson [T-break Tech (Middle East)]
Pfizers biosimilar to blockbuster anemia meds Epogen and Procrit won the support of an FDA expert panel on Thursday, moving another step closer to a potential approval. Indeed, ahead of the panels meeting, FDA reviewers called the Pfizer med highly similar to the reference product, epoetin alfa, sold by Amgen as Epogen and Johnson& Johnson under th
5/27/17 - Glenmark gets USFDA`s approval to sell generic blood pressure medicine [Sudan Tribune]
Glenmark Pharmaceuticals today said it has received final approval from the US health regulator for its generic version Olmesartan Medoxomil Tablets, used in treatment of high blood pressure. The approval granted by the US Food and Drug Administration to Glenmark Pharmaceuticals Inc is for multiple strengths of 5 mg, 20 mg and 40 mg, the company sa
5/27/17 - Global Peptide Therapeutics Market & Clinical Trials Insights, 2022 [Sport360]
-Research and Markets has announced the addition of the "Global Peptide Therapeutics Market& Clinical Trials Insight 2022" report to their offering. Global Peptide Therapeutics Market& Clinical Trials Insight 2022 report gives comprehensive insight into the various clinical and non-clinical issues involved in the development of global peptide drug.
5/27/17 - Govt Bans Importation Of 49 Medicines
The minister, exercising the powers conferred on him by Section 116 of the Public Health Act, 2012, explained that the Food and Drugs Authority would not accept new applications for the registration of a medicine on the restricted list. The move by the government is seen a major boost to the local industry and is in compliance with the Africa Union
Articles(s): 1 - 25 of 250     Next >>     Go To Page:


© 2017 Thomson Reuters. All rights reserved.

Pharmacy News Index
  Drug Delivery Systems
  Drugstores
  FDA Final Approvals
  Front Page Healthcare News
  Generic Drugs
  Hospital Industry
  Internet Pharmacy
  IT in Healthcare
  Medicare & Medicaid
  Over-the-Counter Drugs
  Pharm Industry Trends and Policy
  Pharmaceutical Development
  Pharmaceutical Industry

FEATURED CE LESSON

Legal & Practical Issues in Compounding Pharmacy
This lesson is supported by:
RxSchool
Telepharmacy- Remote Delivery of Pharmacy Services
This lesson is supported by:
RxSchool
Men's Health in Older Adults: Benign Prostatic Hyperplasia and Erectile Dysfunction
This lesson is supported by:
RxSchool
Pharmacy Spanish
This lesson is supported by:
RxSchool
Drug Therapy Management Series Part III: Geriatric Disorders
This lesson is supported by:
RxSchool

Special Announcement

Free Membership
Enjoy Drug Search, industry newsletters and more...


Websites » RxCareerCenter.comRxSchool.comClubStaffing.comNursingJobSource.comRN.com
Copyright © 2017 Pharmacy Choice - All rights reserved.
Terms and Conditions | Privacy Statement
888-682-4415